Laman UtamaBCRX • NASDAQ
add
BioCryst Pharmaceuticals Inc
$6.42
Selepas Waktu Dagangan:(0.47%)+0.030
$6.45
Tutup: 14 Okt, 5:50:34 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$7.04
Julat hari
$6.00 - $6.98
Julat tahun
$6.00 - $11.31
Permodalan pasaran
1.35B USD
Bilangan Purata
3.08J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 163.35J | 49.41% |
Perbelanjaan pengendalian | 87.38J | 42.67% |
Pendapatan bersih | 5.08J | 140.12% |
Margin untung bersih | 3.11 | 126.83% |
Pendapatan bagi setiap syer | 0.04 | 163.33% |
EBITDA | 30.12J | 231.63% |
Kadar cukai berkesan | 21.60% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 260.04J | -4.41% |
Jumlah aset | 457.19J | -3.22% |
Jumlah liabiliti | 878.78J | -7.30% |
Jumlah ekuiti | -421.59J | — |
Syer tertunggak | 209.92J | — |
Harga kepada buku | -3.50 | — |
Pulangan pada aset | 15.89% | — |
Pulangan pada modal | 21.44% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 5.08J | 140.12% |
Tunai daripada operasi | 41.30J | 3,119.15% |
Tunai daripada pelaburan | 29.13J | 1,289.34% |
Tunai daripada pembiayaan | -73.69J | -3,648.02% |
Perubahan bersih dalam tunai | -16.96J | -186.13% |
Aliran tunai bebas | 39.77J | 38.59% |
Perihal
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
Diasaskan
1986
Ibu pejabat
Tapak web
Pekerja
580
